MNKD Message Board Post 9183138 | MannKind Corporation
home / stock / mnkd / mnkd message board
OTCAlerts
(investorshub)
Posted on: Nov/10/2022 16:08:10
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170419334
Technosphere Insulin (TI) peaked 30 minutes faster and
News, Short Squeeze, Breakout and More Instantly...
-
Study proves inhaled insulin is as effective as usual care (primarily automated insulin delivery pumps or multiple daily injections) for adults living with T1D meeting the primary endpoint Patients utilizing inhaled insulin reached target A1c (less than 7%) 30% of the time compared to 17%...
-
17-week endpoint results comparing Afrezza ® head-to-head with multiple daily injections (MDI) and insulin pumps INHALE-3 Study Protocol Chair Dr. Irl. B. Hirsh joined by investigational team to deliver presentation moderated by Jaeb Center founder Dr. Roy W. Beck ...
-
Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation PR Newswire Cross license involves Pulmatrix iSPERSE™ technology and MannKind's Cricket ® inhalation device. Pulmatrix transferring leased building,...